Advertisement
UK markets close in 6 hours 56 minutes
  • FTSE 100

    7,837.54
    -39.51 (-0.50%)
     
  • FTSE 250

    19,283.06
    -167.61 (-0.86%)
     
  • AIM

    740.81
    -4.48 (-0.60%)
     
  • GBP/EUR

    1.1677
    -0.0006 (-0.05%)
     
  • GBP/USD

    1.2437
    -0.0001 (-0.01%)
     
  • Bitcoin GBP

    51,781.41
    +2,514.30 (+5.10%)
     
  • CMC Crypto 200

    1,337.34
    +24.72 (+1.89%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    82.90
    +0.17 (+0.21%)
     
  • GOLD FUTURES

    2,397.00
    -1.00 (-0.04%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,699.02
    -138.38 (-0.78%)
     
  • CAC 40

    7,979.26
    -44.00 (-0.55%)
     

Pfizer Has Received Commercial Rights for Cresemba in Europe

On June 14, 2017, Pfizer (PFE) announced an agreement with Basilea Pharmaceutica for exclusive commercial rights for Cresemba in Europe.